HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘Beneficial Bacteria’ Gets Novel Food Approval From EFSA

Executive Summary

EFSA has given a positive opinion on the safety of Akkermansia muciniphila as a novel food. Naturally occurring in the human gut, A. muciniphila can help to control fat storage and glucose metabolism, claims applicant A-Mansia.

You may also be interested in...



EFSA Considers Vitamin D Max Levels As Part Of VMS Evidence Review

Vitamin D is one of eight micronutrients being reviewed by the European Food Safety Authority in terms of tolerable upper intake levels (ULs).

EU Health Claim Rejected For US-Made Grape Seed Extract

The European Food Safety Authority has rejected a health claim related to MegaNatural‐BP grape seed extract and maintenance of normal blood pressure. The ingredient features in dietary supplements marketed in the US by companies including GNC and Healthy Origins.

Haleon Invests In Healthcare Professionals With Centre for Human Sciences Launch

Haleon has established its Centre for Human Sciences to foster collaboration between academics in human behavior and frontline healthcare professionals. The consumer health giant hopes the initiative will help solve some of the most pressing challenges facing healthcare professionals.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel